Search clinical trials for: Imatinib mesylate and zoledronic acid

Total 25628 results

Washington University School of Medicine
Novartis Pharmaceuticals

Terminated

Study of Zoledronic Acid Versus Observation on Bone Mineral Density and Incidence of Micrometastasis in Women Undergoing Pelvic Radiation for Cervical Cancer

Uterine Cervical Neoplasms

United States
University Health Network, Toronto

Completed

Duration of Suppression of Bone Turnover Following Treatment With Zoledronic Acid in Men With Metastatic CRPC (SubDueP)

Metastatic Prostate Cancer | Bone Metastasis

Canada
Roswell Park Cancer Institute

Terminated

Paricalcitol and Zoledronate in Treating Patients With Relapsed or Refractory Multiple Myeloma or Other Plasma Cell Disorders

Multiple Myeloma and Plasma Cell Neoplasm

United States
Novartis Pharmaceuticals

Completed

Effect of Zoledronic Acid in Patients With Prostate Cancer and Bone Metastasis

Prostate Cancer Patients With Bone Metastasis
Royal Prince Alfred Hospital, Sydney, Australia
Novartis

Completed

The Effect of Zoledronic Acid on Bone Density in Liver Transplant Patients

Liver Transplantation | Osteoporosis | Fractures

Australia
Xijing Hospital

Recruiting

Exploring the Molecular Mechanism Based on KIT Mutation (EMMBKM)

GIST

China
Gruppo Italiano Malattie EMatologiche dell'Adulto

Active, not recruiting

Sustained Treatment-free Remission in BCR-ABL+ Chronic Myeloid Leukemia (SUSTRENIM)

Chronyc Myeloid Leukemia

Netherlands, Italy
University of Sao Paulo General Hospital

Unknown

Imatinib Discontinuation in Patients With Chronic Myeloid Leukemia Chronic Phase With Sustained MR4log

Leukemia, Myeloid, Chronic-Phase

Brazil
Shenzhen People's Hospital

Recruiting

Denosumab vs Zoledronic Acid and Osteoporotic Compression Fracture

Denosumab vs Zoledronate

China
Emory University
Novartis

Terminated

Phase II Trial of Gleevec and Taxotere as a Combined Regimen for Advanced Gastric Adenocarcinoma

Gastric Adenocarcinoma

United States
National Cancer Institute (NCI)

Terminated

Imatinib Mesylate in Treating Patients With Progressive, Refractory, or Recurrent Stage II or Stage III Testicular or Ovarian Cancer

Testicular Seminoma | Recurrent Ovarian Germ Cell Tumor | Stage II Ovarian Germ Cell Tumor | Stage III Ovarian Germ Cell Tumor | Ovarian Dysgerminoma | Recurrent Malignant Testicular Germ Cell Tumor | Stage II Malignant Testicular Germ Cell Tumor | Stage III Malignant Testicular Germ Cell Tumor

United States
Hikma Pharmaceuticals LLC

Completed

Study of Cemivil® (Imatinib) in Chronic Myeloid Leukemia Patients in Jordan (CCMLJ)

Chronic Myeloid Leukemia, Chronic Phase

Jordan
Affiliated Hospital of Hebei University

Unknown

A Study of Apatinib Plus Docetaxel for Treatment of Advanced Non-squamous Non-small Cell Lung Cancer With Bone Metastases

Non-squamous Non-small Cell Lung Cancer

China
The University of Hong Kong

Unknown

The Efficacy and Safety of Induction-Maintenance Protocol for Patients With Chronic Myelogenous Leukaemia

Chronic Myeloid Leukemia | Philadelphia Chromosome Positive CML

Hong Kong
Peking University People's Hospital
Peking University Shougang Hospital; Peking University International Hospital

Withdrawn

Apatinib for Advanced Soft Tissue Sarcoma Patients: a Phase 2, Multicenter Trial

Advanced Cancer | Soft Tissue Sarcoma Adult

China
University of Auckland, New Zealand
Leukaemia & Blood Cancer New Zealand

Active, not recruiting

KISS Study: Kinase Inhibition With Sprycel Start up (KISS)

Chronic Myeloid Leukemia

New Zealand
National Cancer Institute (NCI)
Eastern Cooperative Oncology Group; NCIC Clinical Trials Group; Southwest Oncology...

Terminated

Comparison of Two Different Doses of STI571 in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor

Gastrointestinal Stromal Tumor

United States, Canada, Puerto Rico
Hoffmann-La Roche

Terminated

A Study to Assess the Efficacy of Intravenous/Oral Bondronat (Ibandronate) in Patients With Metastatic Bone Disease Experiencing Moderate to Severe Pain

Pain | Neoplasm Metastasis | Bone Neoplasm

United States, Italy, Chile, Russian Federation, Hungary, United Kingdom, Poland, Guatemala, Germany, Mexico, Puerto Rico, Greece, Australia, Switzerland, Argentina, Panama
Sun Yat-sen University

Recruiting

HAIC Combined Withzoledronic Acid for the Prevention of Bone Metastases in Advanced HCC

Hepatocellular Carcinoma

China
Daping Hospital and the Research Institute of Surgery...

Unknown

Zoledronic Acid Combined Radiotherapy for Bone Metastasis of Non-small Cell Lung Cancer

Non-small Cell Lung Cancer | Bone Metastasis
University Health Network, Toronto
Canadian Breast Cancer Foundation

Completed

Suppression of Bone Turnover Following Treatment With Zoledronic Acid in Patients With Metastatic Breast Cancer: Duration of Effect (SuBDuE)

Metastatic Breast Cancer With Bone Involvement

Canada
Novartis Pharmaceuticals

Completed

Safety and Efficacy of Zoledronic Acid in Patients With Breast Cancer With Metastatic Bone Lesions

Breast Cancer With Bone Metastasis

Italy
National Taiwan University Hospital

Recruiting

The Optimal Long Term Treatment Strategy of Anti-resorptive Medications---The Extension of Denosumab Sequential Therapy

Osteoporosis | Bone Mineral Density

Taiwan
Nantes University Hospital

Terminated

Bone Demineralization Lesions in the Injured Marrow: Efficacy and Tolerability of Administration Early and Repeated the Zoledronic Acid. Comparative Study, Prospective, Double-blind Controlled (DBMZol) (DBMZol)

Bone Demineralization Lesions in the Injured Marrow

France
Novartis Pharmaceuticals
University of Athens

Completed

Effect Of Zoledronic Acid On Circulating And Bone Marrow-Residing Prostate Cancer Cells In Patients With Clinically Localized Prostate Cancer

Prostate Cancer

Greece
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Single Dose of 5 mg Zoledronic Acid in Chinese Patients With Paget's Disease of Bone (PDB)

Paget's Disease of Bone

China
Novartis Pharmaceuticals

Completed

The Use of Zoledronic Acid in Men on Androgen Deprivation Therapy for Prostate Cancer With Preexisting Osteoporosis

Prostate Cancer

United States
University of Sao Paulo General Hospital
Novartis

Unknown

The Use of Zoledronic Acid to Complex Regional Pain Syndrome (Aclasta)

Complex Regional Pain Syndromes

Brazil
Tehran University of Medical Sciences
Novartis

Unknown

Zoledronic Acid for the Prevention of Bone Loss Post-bone Marrow Transplantation for Thalassemia Major Patients

Bone Marrow Transplantation | Beta-Thalassemia

Iran, Islamic Republic of
Peking University Cancer Hospital & Institute

Unknown

PD-1 Antibody SHR-1210 Combined With Apatinib of First-line Treatment of Advanced Acral Melanoma

Melanoma

China
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI)

Completed

Docetaxel and Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Breast Cancer

Breast Cancer

United States
Germans Trias i Pujol Hospital

Completed

Efficacy And Security Of Annual And Biennial Zoledronic Acid For Osteoporosis Treatment In An HIV-Infected Patients' Cohort

HIV Infections

Spain
Novartis

Withdrawn

Zoledronic Acid Treatment of Spontaneous Osteonecrosis of the Knee

Osteonecrosis

Australia
Fudan University

Unknown

The Effect of Zoledronic Acid to Bone Fusion and Bone Metabolism of Patients With Lumbar Degenerative Disease After Lumbar Interbody Fusion

Bone Mineral Density | Bone Turnover Markers | Image Changes of Lumbar Fusion

China
The Cleveland Clinic
Novartis

Completed

Safety and Efficacy Study of Concomitant Radiotherapy and Zoledronic Acid for Bone Metastases Palliation

Breast Cancer | Lung Cancer | Prostate Cancer | Bone Metastases
New Mexico Cancer Care Alliance
Novartis; Fred Hutchinson Cancer Center

Completed

Study of Gleevec and Weekly Paclitaxel in Patients Aged 70 or Older With Advanced Non-small Cell Lung Cancer (6137p)

Non-small Cell Lung Cancer

United States
Oslo University Hospital

Suspended

SSG XXV: The Stop-GIST Trial; Discontinuation of Imatinib in Patients With Oligo-metastatic GIST

Gastrointestinal Stromal Tumor

Norway
Imperial College London
Novartis Pharmaceuticals

Completed

Long Term Therapy With Imatinib: Development of Late Side Effects and Compliance to Treatment

Chronic Myeloid Leukemia | Newly Diagnosed

United Kingdom
Bristol-Myers Squibb

Terminated

Study of Dasatinib in Patients With Chronic Phase Chronic Myeloid Leukemia and a Suboptimal Response to Imatinib

Leukemia, Myeloid, Chronic

Sweden, United Kingdom, Russian Federation, France, Germany, Belgium, Portugal, Finland, Norway, Spain, Italy
MedPacto, Inc.

Recruiting

Vactosertib and Imatinib Combination in Patients With Advanced Desmoid Tumor/Aggressive Fibromatosis (DT/AF) (MP-VAC-206)

Dermoid

Korea, Republic of
Heikki Joensuu
Scandinavian Sarcoma Group

Active, not recruiting

Three Versus Five Years of Adjuvant Imatinib as Treatment of Patients With Operable GIST

Sarcoma

Finland
Novartis Pharmaceuticals

Completed

Nilotinib Versus Standard Imatinib (400/600 mg Every Day (QD)) Comparing the Kinetics of Complete Molecular Response for Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) Pts With Evidence of Persistent Leukemia by Real-time Quantitative Polymerase Chain Reaction (RQ-PCR)

CHRONIC MYELOGENOUS LEUKEMIA

Canada, Australia, Spain, Argentina, France, Brazil
Elevar Therapeutics

Completed

A Study Comparing Four Different Rivoceranib Tablets in Healthy Participants

Healthy

United States
Hospital Universitario Dr. Jose E. Gonzalez
Novartis Pharmaceuticals

Completed

Low-dose Nilotinib and Imatinib Combination in Chronic Myeloid Leukemia Patients, With Failure, Suboptimal Response or Treatment Intolerance

Leukemia, Myeloid, Chronic, BCR-ABL Positive

Mexico
Alexandria University
Science, Technology & Innovation Funding Authority (STIFA), Egypt

Unknown

The Safety & Efficacy of Imatinib for the Treatment of SARS-COV-2 Induced Pneumonia

COVID-19
Sichuan Cancer Hospital and Research Institute
Jiangsu HengRui Medicine Co., Ltd.

Completed

Maintenance Therapy of Apatinib After Chemoradiotherapy in Metastatic Nasopharyngeal Carcinoma

Nasopharyngeal Neoplasms

China
Daewoong Pharmaceutical Co. LTD.

Recruiting

Study to Investigate the Efficacy and Safety After Administration of Daewoong Zoledronic Acid for the Purpose of Treatment or Prevention of Osteoporosis

Osteoporosis

Korea, Republic of
Oslo University Hospital
Sykehuset Ostfold; Betanien Hospital

Terminated

Intravenous Bisphosphonate in Stress Fracture Treatment -A Randomised Controlled Double Blinded Multicenter Trial

Stress Fracture Foot | Stress Fracture Ankle

Norway
Spokane Joint Replacement Center

Completed

Effect of Zoledronic Acid on Femoral Bone Loss Following Total Hip Arthroplasty

Osteoporosis
Bayside Health
Novartis

Completed

Comparison of Pamidronate With Zoledronic Acid for Transplant Related Bone Loss Prevention

Osteopenia | Complications of Heart-lung Transplant | Other Complications of Lung Transplant

Search clinical trials for: Imatinib mesylate and zoledronic acid

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gabon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations